BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22620486)

  • 41. Antinuclear antibodies in children with localized scleroderma.
    Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
    J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histopathologic Spectrum of Morphea.
    Chiu YE; Abban CY; Konicke K; Segura A; Sokumbi O
    Am J Dermatopathol; 2021 Jan; 43(1):1-8. PubMed ID: 33337624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose UVA₁ phototherapy for scleroderma: what benefit can we expect?
    Pereira N; Santiago F; Oliveira H; Figueiredo A
    J Eur Acad Dermatol Venereol; 2012 May; 26(5):619-26. PubMed ID: 21635565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma.
    Kikuchi K; Sato S; Kadono T; Ihn H; Takehara K
    Arch Dermatol; 1994 Oct; 130(10):1269-72. PubMed ID: 7944508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic sclerosis with unusual panniculitis and overlying discoid lupus erythematosus-like lesions.
    Oka H; Tanikawa A; Matsuda F; Tanaka M; Nishikawa T
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):627-9. PubMed ID: 16033482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
    Fett N
    Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort.
    Prasad S; Black SM; Zhu JL; Sharma S; Jacobe H
    J Am Acad Dermatol; 2021 Jul; 85(1):114-120. PubMed ID: 33249064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nodular morphea (NM): report of a case of concurrent NM and morphea profunda associated with limited type systemic sclerosis, and overview and definition for NM.
    Ohata C; Yasunaga M; Tsuruta D; Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Hashimoto T
    Eur J Dermatol; 2013; 23(1):87-93. PubMed ID: 23400240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Special features of systemic sclerosis in men].
    Ben Dhaou B; Derbali F; Aydi Z; Baili L; Boussema F; Ketari S; Kochbati S; Cherif O; Rokbani L
    Tunis Med; 2012; 90(8-9):641-5. PubMed ID: 22987380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coexistence of morphea and systemic sclerosis.
    Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
    Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Scleroderma in a hospital setting in Togo].
    Pitche P; Amanga Y; Koumouvi K; Oniankitan O; Mijiyawa M; Tchangaï-Walla K
    Med Trop (Mars); 1998; 58(1):65-8. PubMed ID: 9718559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Borrelia in granuloma annulare, morphea and lichen sclerosus: a PCR-based study and review of the literature.
    Zollinger T; Mertz KD; Schmid M; Schmitt A; Pfaltz M; Kempf W
    J Cutan Pathol; 2010 May; 37(5):571-7. PubMed ID: 20015188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
    Owens GR; Paradis IL; Gryzan S; Medsger TA; Follansbee WP; Klein HA; Dauber JH
    J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Histochemical investigations in scleroderma (author's transl)].
    Kreysel HW; Brügge P; Jänner M; Kimmig J
    MMW Munch Med Wochenschr; 1976 Sep; 118(39):1235-40. PubMed ID: 135207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A patient with plaque type morphea mimicking systemic lupus erythematosus.
    Wardhana ; Datau EA
    Acta Med Indones; 2015 Apr; 47(2):146-52. PubMed ID: 26260557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dermoscopy of Morphea and Cutaneous Lichen Sclerosus: Clinicopathological Correlation Study and Comparative Analysis.
    Errichetti E; Lallas A; Apalla Z; Di Stefani A; Stinco G
    Dermatology; 2017; 233(6):462-470. PubMed ID: 29237158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.